# Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/targeted-release-budesonide-modifies-key-pathogenic-biomarkers-in-immunoglobulin/

## Facts

| Field | Value |
| --- | --- |
| Author Names | David Wimbury,Masahiro Muto,Jasraj S. Bhachu,Katrin Scionti,Jeremy R. Glissen Brown,Karen Molyneux,Claudia Seikrit,Dita Maixnerová,Laura Pérez‐Alós,Peter Garred,Jürgen Floege,Vladimı́r Tesař,Bengt Fellström,Rosanna Coppo,Jonathan Barratt |
| Citations | 55 |
| DOI | 10.1016/j.kint.2023.11.003 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.kidney-international.org/article/S0085253823007780/pdf |
| OpenAlex ID | https://openalex.org/W4389001266 |
| PMID | 38008160 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Katrin Scionti](https://scholariq.org/researchers/katrin-scionti/)
- [Karen Molyneux](https://scholariq.org/researchers/karen-molyneux/)

## Paper journal

- [Kidney International](https://scholariq.org/journals/kidney-international/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.